Wildcat Capital Management, LLC - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 45 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Wildcat Capital Management, LLC ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2019$206,000
-90.5%
23,902
-87.7%
0.09%
-90.6%
Q2 2019$2,167,000
-16.2%
194,4990.0%0.94%
-38.1%
Q1 2019$2,587,000
-13.9%
194,499
-0.0%
1.52%
-23.2%
Q4 2018$3,005,000
+8.5%
194,5000.0%1.98%
-7.6%
Q3 2018$2,770,000194,5002.14%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q3 2018
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,561,150$6,125,1783.26%
Redmile Group, LLC 8,509,126$14,635,6970.70%
Avidity Partners Management LP 2,733,800$4,702,1360.19%
Frazier Life Sciences Management, L.P. 1,430,878$2,461,1100.16%
Artia Global Partners LP 95,170$163,6920.07%
Worth Venture Partners, LLC 43,772$75,2880.04%
SkyOak Wealth, LLC 60,875$104,7050.03%
Point72 Asset Management, L.P. 5,924,867$10,190,7710.03%
CORNERCAP INVESTMENT COUNSEL INC 76,811$132,1150.02%
Houlihan Financial Resource Group, Ltd. 20,000$380.02%
View complete list of GRITSTONE ONCOLOGY INC shareholders